Your browser doesn't support javascript.
loading
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis.
Pollak, Thomas A; Vincent, Angela; Iyegbe, Conrad; Coutinho, Ester; Jacobson, Leslie; Rujescu, Dan; Stone, James; Jezequel, Julie; Rogemond, Veronique; Jamain, Stephane; Groc, Laurent; David, Anthony; Egerton, Alice; Kahn, Rene S; Honnorat, Jerome; Dazzan, Paola; Leboyer, Marion; McGuire, Philip.
Affiliation
  • Pollak TA; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, University College London, London, United Kingdom. Electronic address: thomas.pollak@kcl.ac.uk
  • Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom.
  • Iyegbe C; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom.
  • Coutinho E; Division of Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom.
  • Jacobson L; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom.
  • Rujescu D; Department of Psychiatry, Psychotherapy, and Psychosomatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
  • Stone J; Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, University College London, London, United Kingdom.
  • Jezequel J; Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom; Interdisciplinary Institute for Neuroscience, University of Bordeaux, Bordeaux, France.
  • Rogemond V; Rare Disease Reference Center on Autoimmune Encephalitis, Hospices Civils de Lyon, Institut NeuroMyoGene Institut National de la Santé et de la Recherche Médicale U1217/Centre National de la Recherche Scientifique, University Claude Bernard, Universite de Lyon, Lyon, France.
  • Jamain S; Psychiatry and Addictology Department (DMU IMPACT), University Paris Est Créteil, Hopitaux Universitaires Henri Mondor, L'Assistance Publique-Hôpitaux de Paris, Créteil, France.
  • Groc L; Interdisciplinary Institute for Neuroscience, University of Bordeaux, Bordeaux, France.
  • David A; Institute of Mental Health, University College London, London, United Kingdom.
  • Egerton A; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom.
  • Kahn RS; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Honnorat J; Rare Disease Reference Center on Autoimmune Encephalitis, Hospices Civils de Lyon, Institut NeuroMyoGene Institut National de la Santé et de la Recherche Médicale U1217/Centre National de la Recherche Scientifique, University Claude Bernard, Universite de Lyon, Lyon, France.
  • Dazzan P; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom.
  • Leboyer M; Psychiatry and Addictology Department (DMU IMPACT), University Paris Est Créteil, Hopitaux Universitaires Henri Mondor, L'Assistance Publique-Hôpitaux de Paris, Créteil, France; Translational Neuropsychiatry Laboratory, Institut National de la Santé et de la Recherche Médicale U955, Créteil, France;
  • McGuire P; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, University College London, London, United Kingdom.
Biol Psychiatry ; 90(1): 9-15, 2021 07 01.
Article in En | MEDLINE | ID: mdl-33536130
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Biol Psychiatry Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Biol Psychiatry Year: 2021 Document type: Article Country of publication: